Growth Factor-mediated Tumor Progression and Metastasis in Cholangiocarcinoma
Korean Journal of Pancreas and Biliary Tract. 2015;20(4):175-189 
Tu1931 Gemcitabine-Eluting Membrane Inhibits Pancreatic/ Cholangiocarcinoma Tumor Growth and Metastasis by Blocking the Epidermal Growth Factor Receptor Signaling Pathway
Gastroenterology. 2015;148(4):S-938
METCAM/MUC18 Promotes Tumor Progression and Metastasis in Most Human Cancers
Tumor Progression and Metastasis. 2020;
228 EPHA2-MEDIATED AKT-MTORC1 AND PYK2-SRC ACTIVATIONS CONTRIBUTE TUMOR GROWTH AND METASTASIS IN CHOLANGIOCARCINOMA
Journal of Hepatology. 2011;54:S95
Transforming growth factor beta and the cell surface in tumor progression
Cancer and Metastasis Reviews. 1993;12(3-4):239-254
Over-Expression of Nerve Growth Factor-β in Human Cholangiocarcinoma QBC939 Cells Promote Tumor Progression
PLoS ONE. 2013;8(4):e62024
Epidermal growth factor induces FoxO1 nuclear exclusion to activate MMP7-mediated metastasis of larynx carcinoma
Tumor Biology. 2014;35(10):9987-9992
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor
Hepatology. 2014;60(2):770-770
Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response
Clinical & Experimental Metastasis. 2007;24(7):521-531
Smad3 is key to TGF-β-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis
Cytokine & Growth Factor Reviews. 2006;17(1-2):19-27